ERBB2 and nasopharyngeal carcinoma: This result differs from a Hong Kong study of 78 Chinese patients with undifferentiated NPC (Ma et al, 2003), in which HER2 overexpression was observed in 31% of the patients and conferred an association with increased stage of disease.